[go: up one dir, main page]

Dhavale et al., 2024 - Google Patents

Structure of alpha-synuclein fibrils derived from human Lewy body dementia tissue

Dhavale et al., 2024

View HTML @Full View
Document ID
5505067646568101499
Author
Dhavale D
Barclay A
Borcik C
Basore K
Berthold D
Gordon I
Liu J
Milchberg M
O’Shea J
Rau M
Smith Z
Sen S
Summers B
Smith J
Warmuth O
Perrin R
Perlmutter J
Chen Q
Fitzpatrick J
Schwieters C
Tajkhorshid E
Rienstra C
Kotzbauer P
Publication year
Publication venue
Nature communications

External Links

Snippet

The defining feature of Parkinson disease (PD) and Lewy body dementia (LBD) is the accumulation of alpha-synuclein (Asyn) fibrils in Lewy bodies and Lewy neurites. Here we develop and validate a method to amplify Asyn fibrils extracted from LBD postmortem tissue …
Continue reading at www.nature.com (HTML) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2814—Dementia; Cognitive disorders
    • G01N2800/2828—Prion diseases
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2814—Dementia; Cognitive disorders
    • G01N2800/2821—Alzheimer
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2835—Movement disorders, e.g. Parkinson, Huntington, Tourette
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
    • G01R33/00—Arrangements or instruments for measuring magnetic variables
    • G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance

Similar Documents

Publication Publication Date Title
Dhavale et al. Structure of alpha-synuclein fibrils derived from human Lewy body dementia tissue
Meier et al. Emerging structural understanding of amyloid fibrils by solid-state NMR
Arseni et al. Structure of pathological TDP-43 filaments from ALS with FTLD
Ma et al. Phosphorylation induces distinct alpha-synuclein strain formation
Xiao et al. Aβ (1–42) fibril structure illuminates self-recognition and replication of amyloid in Alzheimer's disease
Chimon et al. Evidence of fibril-like β-sheet structures in a neurotoxic amyloid intermediate of Alzheimer's β-amyloid
Lu et al. β-Sheet core of human prion protein amyloid fibrils as determined by hydrogen/deuterium exchange
Tuttle et al. Solid-state NMR structure of a pathogenic fibril of full-length human α-synuclein
Rodriguez et al. Structure of the toxic core of α-synuclein from invisible crystals
Falsone et al. SERF protein is a direct modifier of amyloid fiber assembly
Pedersen et al. Analysis of protein aggregation in neurodegenerative disease
Siddiqua et al. Conformational basis for asymmetric seeding barrier in filaments of three-and four-repeat tau
Mompeán et al. Structural evidence of amyloid fibril formation in the putative aggregation domain of TDP-43
Zhang et al. Supertertiary structure of the MAGUK core from PSD-95
Gu et al. A new structural model of Alzheimer’s Aβ42 fibrils based on electron paramagnetic resonance data and Rosetta modeling
Bisaglia et al. Structure and topology of the non‐amyloid‐β component fragment of human α‐synuclein bound to micelles: Implications for the aggregation process
Fan et al. Conformational change of α-synuclein fibrils in cerebrospinal fluid from different clinical phases of Parkinson’s disease
Conicella et al. The C-terminal threonine of Aβ43 nucleates toxic aggregation via structural and dynamical changes in monomers and protofibrils
Holec et al. Consequences of variability in α-synuclein fibril structure on strain biology
Hu et al. Phosphorylation and O-GlcNAcylation at the same α-synuclein site generate distinct fibril structures
Liang et al. A SUMO1-derived peptide targeting SUMO-interacting motif inhibits α-Synuclein aggregation
Zhang et al. Conformational dynamics of an α-synuclein fibril upon receptor binding revealed by insensitive nuclei enhanced by polarization transfer-based solid-state nuclear magnetic resonance and cryo-electron microscopy
Ranjan et al. Differential copper binding to alpha-synuclein and its disease-associated mutants affect the aggregation and amyloid formation
Bateman et al. Experimentally derived structural constraints for amyloid fibrils of wild-type transthyretin
Dhavale et al. A sensitive assay reveals structural requirements for α-synuclein fibril growth